Abstract
Scleroderma typically manifests as fibrosis of the skin, but may also involve other organs, particularly the lungs. Interstitial lung disease and functional abnormalities are observed in the majority of patients. The aim of this study was to evaluate radiological changes in the lungs and their correlation with functional disorders in scleroderma patients. The study was conducted in 37 scleroderma patients (F/M-31/6). High resolution computed tomography (HRCT), Warrick score system and spirometry, body plethysmography, and lung diffusion examinations (DLco) were performed. The HRCT showed septal and subpleural lines in 70%, ground-glass opacities in 51%, and honeycomb lungs in 30% of the cases. The DLco values were decreased in 92% of the patients. Total lung capacity (TLC) showed a restrictive pattern in 24% of the patients, and only in 11% of them obstruction predominated. The Warrick score correlated inversely with both DLco (r=0.36; p>0.05). Interstitial lung disease often coexists with scleroderma and is accompanied by functional lung abnormalities.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Avouac, J., Kowal-Bielecka, O., Landewé, R., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., Földvari, I., Furst, D. E., Müller-Ladner, U., Seibold, J., Silver, R. M., Takehara, K., Garay Toth, B., Tyndall, A., Valentini, G., van den Hoogen, F., Wigley, F., Zulian, F., Matucci-Cerinic, M., & EUSTAR Coauthors. (2009). European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: Methods of elaboration and results of systematic literature research. Annals of the Rheumatic Diseases, 68, 629–634.
Behr, J., & Furst, D. E. (2008). Pulmonary function tests. Rheumatology, 47, 65–67.
Bellia, M., Cannizarro, F., Scichilone, N., Riili, M., Triolo, G., Midiri, M., & Lagalla, R. (2009). HRCT and scleroderma: Semiquantative evaluation of lung damage and functional abnormalities. La Radiologia Medica, 114, 190–203.
Bussone, G., & Mouthon, L. (2011). Interstitial lung disease in systemic sclerosis. Autoimmunity Reviews, 10, 248–255.
Cottin, V. (2007). Interstitial lung disease in connective diseases. La Revue du Praticien, 57, 2235–2242.
Dougados, M., Betteridge, N., Burmester, G. R., Euller-Ziegler, L., Guillemin, F., Hirvonen, J., Lloyd, J., Ozen, S., Da Silva, J. A. P., Emery, P., Kalden, J. R., Kvien, T., Matucci-Cerinic, M., & Smolen, J. (2004). EULAR standarised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by EULAR standing committees. Annals of the Rheumatic Diseases, 63, 1172–1176.
Goldin, J. G., Lynch, D. A., Strollo, D. C., Suh, R. D., Schraufnagel, D. E., Clements, P. J., Elashoff, R. M., Furst, D. E., Vasunilashorn, S., McNitt-Gray, M., Brown, M. S., Toth, M. D., & Taskin, D. P. (2008). High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest, 134, 358–367.
Hansen, J. E., Sun, X. G., & Wasserman, K. (2007). Spirometric criteria for airway obstruction. Use percentage of FEV1/FVC ratio below the fifth percentile, not 70%. Chest, 131, 349–355.
Ioannidis, J. P. A., Vlachoyannopoulos, P. G., Haldich, A. B., Medsger, T. A., Jr., Lucas, M., Michet, C. J., Kuwana, M., Yasuoka, H., van den Hoogen, F., Te Boome, L., van Laar, J. M., Verbeet, N. L., Matucci-Cerinic, M., Georgountzos, A., & Moutsopoulos, H. M. (2005). Mortality in systemic sclerosis: An international meta-analysis of individual patient data. American Journal of Medicine, 118, 2–10.
Kaloudi, O., Miniati, I., Alari, S., & Matucci-Cerinic, M. (2007). Interstitial lung disease in systemic sclerosis. Internal and Emergency Medicine, 4, 250–255.
Kowal-Bielecka, O., Landewé, R., Avouac, J., & EUSTAR Coauthors. (2009). EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR scleroderma trials and research group (EUSRAR). Annals of the Rheumatic Diseases, 68, 620–628.
Launay, D., Remy-Jardin, M., Michon-Pasturel, U., Mastora, I., Hachulla, E., Lambert, M., Delannoy, V., Queyrel, V., Duhamel, A., Matran, R., De Grotte, P., & Hatron, P. Y. (2006). High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. Journal of Rheumatology, 33, 1789–1801.
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., Gustafsson, P., Hankinson, J., Jensen, R., McKay, R., Miller, M. R., Navajas, D., Pedersen, O. F., Pellegrino, R., & Wagner, J. (2005). Standardisation of the single-breath determination of carbon monoxide uptake in the lung. European Respiratory Journal, 26, 720–735.
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., Ven der Grinten, C. P. M., Gustafsson, P., Jensen, R., Johnson, D. C., McIntyre, N., McKay, R., Navajas, D., Pedersen, O. F., Pellegrino, R., Viegi, G., & Wagner, J. (2005). Standardisation of spirometry. European Respiratory Journal, 26, 319–338.
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R., Casaburi, R., Coates, A., Ven der Grinten, C. P. M., Gustafsson, P., Hankinson, J., Jensen, R., Johnson, D. C., McIntyre, N., McKay, R., Miller, M. R., Navajas, D., Pedersen, O. F., & Wagner, J. (2005). Interpretative strategies for lung function tests. European Respiratory Journal, 26, 948–968.
Wagner, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., Ven der Grinten, C. P. M., Gustafsson, P., Hankinson, J., Jensen, R., Johnson, D. C., McIntyre, N., McKay, R., Miller, M. R., Navajas, D., Pellegrino, R., & Viegi, G. (2005). Standardisation of the measurement of lung volumes. European Respiratory Journal, 26, 511–522.
Warrick, J. H., Bhalla, M., Schabel, S. J., & Silver, R. M. (1991). High resolution computed tomography in early scleroderma lung disease. Journal of Rheumatology, 18, 1520–1528.
Wells, A. U. (2008). High-resolution computed tomography and scleroderma lung disease. Rheumatology, 47, 59–61.
Conflicts of Interest: The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Piorunek, T. et al. (2013). Lung Impairment in Scleroderma. In: Pokorski, M. (eds) Respiratory Regulation - Clinical Advances. Advances in Experimental Medicine and Biology, vol 755. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4546-9_20
Download citation
DOI: https://doi.org/10.1007/978-94-007-4546-9_20
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4545-2
Online ISBN: 978-94-007-4546-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)